{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:56:02Z","timestamp":1781585762285,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00467-020-04841-8","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T23:05:54Z","timestamp":1610147154000},"page":"1465-1472","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Urinary biomarkers as point-of-care tests for predicting progressive deterioration of kidney function in congenital anomalies of kidney and urinary tract: trefoil family factors (TFFs) as the\u00a0emerging biomarkers"],"prefix":"10.1007","volume":"36","author":[{"given":"Sachit","family":"Anand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minu","family":"Bajpai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tripti","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"key":"4841_CR1","doi-asserted-by":"publisher","first-page":"723","DOI":"10.2215\/CJN.12581019","volume":"15","author":"V Murugapoopathy","year":"2020","unstructured":"Murugapoopathy V, Gupta IR (2020) A primer on congenital anomalies of the kidneys and urinary tracts. Clin J Am Soc Nephrol 15:723\u2013731","journal-title":"Clin J Am Soc Nephrol"},{"key":"4841_CR2","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.semnephrol.2010.06.004","volume":"30","author":"HR Toka","year":"2010","unstructured":"Toka HR, Toka O, Hariri A, Nguyen HT (2010) Congenital anomalies of kidney and urinary tract. Semin Nephrol 30:374\u2013386","journal-title":"Semin Nephrol"},{"key":"4841_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2215\/CJN.03310412","volume":"8","author":"E W\u00fchl","year":"2013","unstructured":"W\u00fchl E, van Stralen KJ, Verrina E, Bjerre A, Wanner C, Heaf JG, Zurriaga O, Hoitsma A, Niaudet P, Palsson R, Ravani P, Jager KJ, Schaefer F (2013) Timing and outcome of renal replacement therapy in patients with congenital malformations of the kidney and urinary tract. Clin J Am Soc Nephrol 8:67\u201374","journal-title":"Clin J Am Soc Nephrol"},{"key":"4841_CR4","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1007\/s00467-013-2506-8","volume":"28","author":"A Mandelia","year":"2013","unstructured":"Mandelia A, Bajpai M, Agarwala S, Gupta AK, Kumar R, Ali A (2013) The role of urinary TGF-\u03b21, TNF-\u03b1, IL-6 and microalbuminuria for monitoring therapy in posterior urethral valves. Pediatr Nephrol 28:1991\u20132001","journal-title":"Pediatr Nephrol"},{"key":"4841_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00441-009-0913-8","volume":"339","author":"M Rinnert","year":"2010","unstructured":"Rinnert M, Hinz M, Buhtz P, Reiher F, Lessel W, Hoffmann W (2010) Synthesis and localization of trefoil factor family (TFF) peptides in the human urinary tract and TFF2 excretion into the urine. Cell Tissue Res 339:639\u2013647","journal-title":"Cell Tissue Res"},{"key":"4841_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1515\/bmc-2015-0020","volume":"6","author":"M Busch","year":"2015","unstructured":"Busch M, D\u00fcnker N (2015) Trefoil factor family peptides--friends or foes? Biomol Concepts 6:343\u2013359","journal-title":"Biomol Concepts"},{"key":"4841_CR7","doi-asserted-by":"publisher","first-page":"e80271","DOI":"10.1371\/journal.pone.0080271","volume":"8","author":"TY Du","year":"2013","unstructured":"Du TY, Luo HM, Qin HC, Wang F, Wang Q, Xiang Y, Zhang Y (2013) Circulating serum trefoil factor 3 (TFF3) is dramatically increased in chronic kidney disease. PLoS One 8:e80271","journal-title":"PLoS One"},{"key":"4841_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1053\/j.ajkd.2008.01.020","volume":"52","author":"D Bolignano","year":"2008","unstructured":"Bolignano D, Donato V, Coppolino G, Campo S, Buemi A, Lacquaniti A, Buemi M (2008) Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis 52:595\u2013605","journal-title":"Am J Kidney Dis"},{"key":"4841_CR9","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1073\/pnas.0510847103","volume":"103","author":"T Berger","year":"2006","unstructured":"Berger T, Togawa A, Duncan GS, Elia AJ, You-Ten A, Wakeham A, Fong HEH, Cheung CC, Mak TW (2006) Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci U S A 103:1834\u20131839","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4841_CR10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00467-016-3540-0","volume":"32","author":"CS Forster","year":"2017","unstructured":"Forster CS, Devarajan P (2017) Neutrophil gelatinase-associated lipocalin: utility in urologic conditions. Pediatr Nephrol 32:377\u2013381","journal-title":"Pediatr Nephrol"},{"key":"4841_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.urology.2020.05.050","volume":"143","author":"L Kovacevic","year":"2020","unstructured":"Kovacevic L, Lu H, Kovacevic N, Thomas R, Lakshmanan Y (2020) Cystatin C, Neutrophil gelatinase-associated lipocalin, and lysozyme C: urinary biomarkers for detection of early kidney dysfunction in children with urolithiasis. Urology 143:221\u2013226","journal-title":"Urology"},{"key":"4841_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1442-200X.2010.03067.x","volume":"52","author":"M Nishida","year":"2010","unstructured":"Nishida M, Kawakatsu H, Okumura Y, Hamaoka K (2010) Serum and urinary neutrophil gelatinase-associated lipocalin levels in children with chronic renal diseases. Pediatr Int 52:563\u2013568","journal-title":"Pediatr Int"},{"key":"4841_CR13","doi-asserted-by":"publisher","first-page":"340","DOI":"10.4103\/ijn.IJN_276_18","volume":"29","author":"I Jagadesan","year":"2019","unstructured":"Jagadesan I, Agarwal I, Chaturvedi S, Jose A, Sahni RD, Fleming JJ (2019) Urinary neutrophil gelatinase associated lipocalin - a sensitive marker for urinary tract infection in children. Indian J Nephrol 29:340\u2013344","journal-title":"Indian J Nephrol"},{"key":"4841_CR14","first-page":"e56","volume":"8","author":"A Abbasi","year":"2020","unstructured":"Abbasi A, Nabizadeh F, Gardeh M, Mohamed Ali K, Yousefifard M, Hosseini M (2020) Discriminatory precision of neutrophil gelatinase-associated lipocalin in detection of urinary tract infection in children: a systematic review and meta-analysis. Arch Acad Emerg Med 8:e56","journal-title":"Arch Acad Emerg Med"},{"key":"4841_CR15","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3343\/alm.2014.34.5.354","volume":"34","author":"BH Kim","year":"2014","unstructured":"Kim BH, Yu N, Kim HR, Yun KW, Lim IS, Kim TH, Lee MK (2014) Evaluation of the optimal neutrophil gelatinase-associated lipocalin value as a screening biomarker for urinary tract infections in children. Ann Lab Med 34:354\u2013359","journal-title":"Ann Lab Med"},{"key":"4841_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1524-6175.2004.4064.x","volume":"6","author":"RD Toto","year":"2004","unstructured":"Toto RD (2004) Microalbuminuria: definition, detection, and clinical significance. J Clin Hypertens 6:2\u20137","journal-title":"J Clin Hypertens"},{"key":"4841_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13052-019-0635-9","volume":"45","author":"ZY Li","year":"2019","unstructured":"Li ZY, Chen YM, Qiu LQ, Chen DQ, Hu CG, Xu JY, Zhang XH (2019) Prevalence, types, and malformations in congenital anomalies of the kidney and urinary tract in newborns: a retrospective hospital-based study. Ital J Pediatr 45:50","journal-title":"Ital J Pediatr"},{"key":"4841_CR18","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s13312-019-1556-9","volume":"56","author":"BH Kumar","year":"2019","unstructured":"Kumar BH, Krishnamurthy S, Chandrasekaran V, Jindal B, Ananthakrishnan R (2019) Clinical spectrum of congenital anomalies of kidney and urinary tract in children. Indian Pediatr 56:566\u2013570","journal-title":"Indian Pediatr"},{"key":"4841_CR19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/nep.12414","volume":"20","author":"NA Soliman","year":"2015","unstructured":"Soliman NA, Ali RI, Ghobrial EE, Habib EI, Ziada AM (2015) Pattern of clinical presentation of congenital anomalies of the kidney and urinary tract among infants and children. Nephrology (Carlton) 20:413\u2013418","journal-title":"Nephrology (Carlton)"},{"key":"4841_CR20","first-page":"665","volume":"53","author":"Q Miao","year":"2015","unstructured":"Miao Q, Shen Q, Xu H, Sun L, Tang X, Fang X, Liu H, Zhai Y, Bi Y, Wang X, Chen H (2015) Etiological analysis of 264 cases with chronic kidney disease stage 2 to 5 in children. Zhonghua Er Ke Za Zhi 53:665\u2013669","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"4841_CR21","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00467-017-3701-9","volume":"33","author":"JH Greenberg","year":"2018","unstructured":"Greenberg JH, Kakajiwala A, Parikh CR, Furth S (2018) Emerging biomarkers of chronic kidney disease in children. Pediatr Nephrol 33:925\u2013933","journal-title":"Pediatr Nephrol"},{"key":"4841_CR22","doi-asserted-by":"publisher","first-page":"3024698","DOI":"10.1155\/2018\/3024698","volume":"2018","author":"T Yamanari","year":"2018","unstructured":"Yamanari T, Sugiyama H, Tanaka K, Morinaga H, Kitagawa M, Onishi A, Ogawa-Akiyama A, Kano Y, Mise K, Ohmoto Y, Shikata K, Wada J (2018) Urine trefoil factors as prognostic biomarkers in chronic kidney disease. Biomed Res Int 2018:3024698","journal-title":"Biomed Res Int"},{"key":"4841_CR23","doi-asserted-by":"publisher","first-page":"e0138312","DOI":"10.1371\/journal.pone.0138312","volume":"10","author":"D Lebherz-Eichinger","year":"2015","unstructured":"Lebherz-Eichinger D, Tudor B, Ankersmit HJ, Reiter T, Haas M, Roth-Walter F, Krenn CG, Roth GA (2015) Trefoil factor 1 excretion is increased in early stages of chronic kidney disease. PLoS One 10:e0138312","journal-title":"PLoS One"},{"key":"4841_CR24","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1007\/s10620-018-5223-0","volume":"63","author":"MC Alvarez","year":"2018","unstructured":"Alvarez MC, Fernandes J, Michel V, Touati E, Ribeiro ML (2018) Effect of Helicobacter pylori Infection on GATA-5 and TFF1 regulation, comparison between pediatric and adult patients. Dig Dis Sci 63:2889\u20132897","journal-title":"Dig Dis Sci"},{"key":"4841_CR25","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1515\/CCLM.2011.667","volume":"49","author":"F Verey","year":"2011","unstructured":"Verey F, Nexo E, Greenwood R, Berry M, Corfield AP (2011) Trefoil factor family peptides are increased in the saliva of children with mucositis. Clin Chem Lab Med 49:2051\u20132055","journal-title":"Clin Chem Lab Med"},{"key":"4841_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3920\/BM2017.0059","volume":"2018","author":"MM Heitkemper","year":"2018","unstructured":"Heitkemper MM, Cain KC, Shulman RJ, Burr RL, Ko C, Hollister EB, Callen N, Zia J, Han CJ, Jarrett ME (2018) Stool and urine trefoil factor 3 levels: associations with symptoms, intestinal permeability, and microbial diversity in irritable bowel syndrome. Benef Microbes 2018:345\u2013355","journal-title":"Benef Microbes"},{"key":"4841_CR27","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1097\/IAE.0000000000001881","volume":"38","author":"M Busch","year":"2018","unstructured":"Busch M, Metz K, Beier M, Biewald E, D\u00fcnker N (2018) Trefoil factor family 1 expression correlates with clinical outcome in patients with retinoblastoma. Retina 38:2422\u20132428","journal-title":"Retina"},{"key":"4841_CR28","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1046\/j.1523-1755.2003.00278.x","volume":"64","author":"M Bajpai","year":"2003","unstructured":"Bajpai M, Pal K, Bal CS, Gupta AK, Pandey RM (2003) Role of plasma renin activity in the management of primary vesicoureteric reflux: a preliminary report. Kidney Int 64:1643\u20131647","journal-title":"Kidney Int"},{"key":"4841_CR29","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1016\/j.juro.2007.08.058","volume":"178","author":"M Bajpai","year":"2007","unstructured":"Bajpai M, Bal CS, Tripathi M, Kalaivani M, Gupta AK (2007) Prenatally diagnosed unilateral hydronephrosis: prognostic significance of plasma renin activity. J Urol 178:2580\u20132584","journal-title":"J Urol"},{"key":"4841_CR30","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1046\/j.1523-1755.2002.00365.x","volume":"61","author":"G Wolf","year":"2002","unstructured":"Wolf G, Wenzel U, Burns KD, Harris RC, Stahl RA, Thaiss F (2002) Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors. Kidney Int 61:1986\u20131995","journal-title":"Kidney Int"},{"key":"4841_CR31","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.peptides.2003.11.019","volume":"25","author":"M Baus-Loncar","year":"2004","unstructured":"Baus-Loncar M, Al-azzeh ED, Romanska H, el Lalani N, Stamp GW, Blin N, Kayademir T (2004) Transcriptional control of TFF3 (intestinal trefoil factor) via promoter binding sites for the nuclear factor kappaB and C\/EBPbeta. Peptides 25:849\u2013854","journal-title":"Peptides"},{"key":"4841_CR32","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00467-011-1773-5","volume":"26","author":"A Wasilewska","year":"2011","unstructured":"Wasilewska A, Taranta-Janusz K, D\u0119bek W, Zoch-Zwierz W, Kuroczycka-Saniutycz E (2011) KIM-1 and NGAL: new markers of obstructive nephropathy. Pediatr Nephrol 26:579\u2013586","journal-title":"Pediatr Nephrol"},{"key":"4841_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00467-015-3194-3","volume":"31","author":"G Parmaks\u0131z","year":"2016","unstructured":"Parmaks\u0131z G, Noyan A, Dursun H, \u0130nce E, Anarat R, Cengiz N (2016) Role of new biomarkers for predicting renal scarring in vesicoureteral reflux: NGAL, KIM-1, and L-FABP. Pediatr Nephrol 31:97\u2013103","journal-title":"Pediatr Nephrol"},{"key":"4841_CR34","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s11255-019-02355-3","volume":"52","author":"A Nickavar","year":"2020","unstructured":"Nickavar A, Valavi E, Safaeian B, Moosavian M (2020) Validity of urine neutrophile gelatinase-associated lipocalin in children with primary vesicoureteral reflux. Int Urol Nephrol 52:599\u2013602","journal-title":"Int Urol Nephrol"},{"key":"4841_CR35","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00467-019-4195-4","volume":"34","author":"D Kostic","year":"2019","unstructured":"Kostic D, Dos Santos Beozzo GPN, do Couto SB, Kato AHT, Lima L, Palmeira P, Krebs VLJ, Bunduki V, Francisco RPV, Zugaib M, de Carvalho WB, Koch VHK (2019) First-year profile of biomarkers for early detection of renal injury in infants with congenital urinary tract obstruction. Pediatr Nephrol 34:1117\u20131128","journal-title":"Pediatr Nephrol"},{"key":"4841_CR36","doi-asserted-by":"publisher","first-page":"e13707","DOI":"10.14814\/phy2.13707","volume":"6","author":"H Saito","year":"2018","unstructured":"Saito H, Tanaka T, Tanaka S, Higashijima Y, Yamaguchi J, Sugahara M, Ito M, Uchida L, Hasegawa S, Wakashima T, Fukui K, Nangaku M (2018) Persistent expression of neutrophil gelatinase-associated lipocalin and M2 macrophage markers and chronic fibrosis after acute kidney injury. Physiol Rep 6:e13707","journal-title":"Physiol Rep"},{"key":"4841_CR37","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1681\/ASN.2011060627","volume":"23","author":"MA Niewczas","year":"2012","unstructured":"Niewczas MA, Gohda T, Skupien J, Smiles AM, Walker WH, Rosetti F, Cullere X, Eckfeldt JH, Doria A, Mayadas TN, Warram JH, Krolewski AS (2012) Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol 23:507\u2013515","journal-title":"J Am Soc Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04841-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-020-04841-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04841-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T16:17:27Z","timestamp":1619713047000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-020-04841-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["4841"],"URL":"https:\/\/doi.org\/10.1007\/s00467-020-04841-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,8]]},"assertion":[{"value":"23 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interests"}},{"value":"The protocol of the study was approved by the institutional review board prior to starting the study (Ref. No. IECPG-524\/29.08.2019, RT-10\/26.09.2019).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from parents for participation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent obtained from parents for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}